4 articles
Moving beyond outdated generalizations about cannabis requires a granular, data-driven look at the Endocannabinoid System (ECS). For the over-40 demographic, the goal is the precise maintenance of vascular elasticity and the careful management of myocardial oxygen demand.
The Endocannabinoid System (ECS) is a primary regulator of cardiovascular stability, mediated by CB1 and CB2 receptors found throughout the heart and vascular tissues. Using cannabis for heart health requires a granular approach to dosage, specific terpene profiles, and an understanding of individual metabolic pathways.
Think of your Endocannabinoid System (ECS) as a biological thermostat for your cardiovascular health. For those navigating heart concerns or entering their senior years, the conversation around cannabis should be about precision rather than intoxication. Not all cannabinoids affect the heart the same way, and choosing the right one is a matter of safety. Emerging research suggests Beta-Caryophyllene (BCP) and Cannabidiol (CBD) may serve as tools for supporting heart health while avoiding the cardiovascular stress associated with high-THC products.
The athletic recovery market is undergoing a data-driven transformation. Elite competitors are cross-referencing wearable biometric data with specific cannabinoid intake. This scrutiny has brought one physiological reality to the forefront: the Heart-Rate Paradox. While THC may offer benefits for analgesic recovery and sleep, it imposes a measurable tax on the cardiovascular system that serious competitors often manage to maintain aerobic efficiency.